This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
males) of HaH patients was selected using stratified systematic sampling methods. It was not stated whether any of the patients were excluded from the initial study sample or refused to participate.
Study design
This was a prospective cohort study, which was conducted in a specialist orthopaedic centre. The authors stated that a quasi-experimental design was adopted. The patients were followed for 6 months. The outcomes were assessed at baseline (preoperatively), on the day of discharge (from the inpatient unit or HaH scheme), 6 weeks postoperatively, and 6 months following surgery. No loss to follow-up occurred. Blinding was not performed because the authors stated that each patient maintained the right to choose the type of rehabilitation intervention.
Analysis of effectiveness
All patients included in the initial study sample were taken into account in the effectiveness study. The primary health outcomes used in the analysis were: a disease-specific measure of osteoarthritis, the Westerns Ontario and McMaster arthritis index (WOMAC), which is a 24-item self-reported index that compares joint pain, stiffness and difficulties with daily activities; satisfaction at the point of discharge, measured using the Hospital Patient Satisfaction Index (HPSI) which is a 21-item self-reported patient satisfaction measure; the incidence of complications (deep vein thrombosis, pulmonary embolism, wound infection, dislocation of hip prosthesis, and pressure ulcers); and the experience of informal carers, as measured through semi-structured interviews.
The study groups were not shown to have been comparable at baseline. The patients' demographic and clinical characteristics were not provided.
Effectiveness results
The results of the WOMAC index suggested that only joint stiffness was significantly different between the groups. The HaH patients reported less joint stiffness than the comparison patients, (p=0.03).
Patient satisfaction was significantly better for HaH patients for 13 of the 21 items considered.
There was no statistically significant difference in the incidence of complications.
Informal carers appear to have preferred HaH as there were 107 positive comments versus 36 negative comments. Also, all but one of the carers stated that they would choose HaH as a referable option to inpatient care for their relative.
There was no difference between male and female carers in terms of help categories or the overall degree of burden or responsibility.
Clinical conclusions
The effectiveness study showed that, compared with the inpatient interventions, the HaH intervention was effective in improving patient and carer satisfaction and in reducing joint stiffness.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used. The analysis was therefore classified as a cost-consequences analysis (CCA).
Direct costs
Discounting was not relevant since the costs were incurred during a short time period. The unit costs were analysed separately from the quantities of resources used. The health services included in the economic evaluation were the length of stay (LOS) in the hospital or in the HaH scheme, visits by the HaH team, community and outpatient services, and the hospital readmission rates. However, the total costs were calculated only on the basis of the mean LOS for both the HaH group and the inpatient group. The savings reported by the informal carers were also evaluated. The cost/resource boundary adopted appears to have been that of the service provider. The resource used and the costs were estimated using actual data coming from the finance department, patient tracking forms, and cross references to the patients' case notes. The dates during which the resources used or prices were collected, were not reported. No price year was given.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included.
Currency

UK pounds sterling ().
Sensitivity analysis
Sensitivity analyses were not conducted.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
The average estimated costs were 2,984.39 per patient episode in the comparison group and 2,332.25 per patient episode in the HaH group.
The difference in costs was 652.04 per patient.
The authors stated that if all 64 HaH patients had remained in hospital, it would have cost an extra 41,720.56 to treat them following the conventional approach.
Only one patient in the HaH group required overnight readmission to the hospital, while another three patients were seen in the outpatient department. Eleven of the 21 carers reported savings due to less travel to the hospital.
Synthesis of costs and benefits
Not relevant because a CCA was conducted. However, the authors stated that it was not necessary to combine the costs and benefits since the HAH strategy dominated the standard approach, which was both more costly and less effective.
